|
Dr. Shapiro has served as director since April 2003. Prior to this, he was Executive Vice President, Worldwide Licensing and External Research at Merck & Co, Inc. where he was responsible for all the basic and preclinical research activities at Merck, then of Worldwide Licensing and External Research, where he directed all of Merck’s research relationships with the academic and industrial biomedical research community. Earlier, he was Professor and Chairman of the Department of Biochemistry at the University of Washington. He is the author of over 120 papers on the molecular regulation of cellular behavior and has served on many institutional advisory boards and review panels. He is currently a director of PureTech Ventures, Momenta Pharmaceuticals (NASDAQ: MNTA), Protein Forest, and Vascular Biogenics, and a trustee of Dickinson College. Dr. Shapiro has a B.S. in Chemistry from Dickinson College and an M.D. from Jefferson Medical College. | 